Thursday, 18 April 2024
Atara Biotherapeutics Inc.
04:22 | 17/3/18
Alpha Beta Stock
Canada's main stock index closed higher Thursday while the Canadian dollar dropped for the third day in a row. The S&P/TSX composite index closed up 17.01 points to 15,670.62, led by financials and energy stocks.
more»
02:52 | 17/3/18
Nasdaq Chronicle
Atara Biotherapeutics, Inc. (ATRA) stock price recent trade pushed it move about -16.03% away from the 52-week high and closed 255.08% away from the 52-week low.
more»
01:00 | 17/3/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today ...
more»
23:41 | 14/3/18
Wall Street Morning
Technical analysis of Atara Biotherapeutics, Inc. (ATRA) stock includes the study of technical indicators and past trends.
more»
14:18 | 14/3/18
Simply Wall St
In December 2017, Atara Biotherapeutics Inc (NASDAQ:ATRA) released its latest earnings announcement, which suggested that losses became smaller relative to the prrior year's level - great news for investors Below, I've laid out key numbers on how ...
more»
13:18 | 14/3/18
StockNewsTimes
Atara Biotherapeutics logo Atara Biotherapeutics Inc (NASDAQ:ATRA) fell 10.4% during mid-day trading on Tuesday . The stock traded as low as $41.00 and last traded at $41.25.
more»
10:30 | 14/3/18
Equities.com
Atara Biotherapeutics Inc. (ATRA) had a rough trading day for Tuesday March 13 as shares tumbled 10.42%, or a loss of $-4.8 per share, to close at $41.25.
more»
07:56 | 13/3/18
Post Analyst
Also, a 24.45% expansion in Fifth Third Bancorp (FITB) witnessed over the past one year opens up opportunity to go after even more gains.
more»
02:52 | 13/3/18
Alpha Beta Stock
U.S. stocks surged on Friday, pushing the Nasdaq composite to a record, after February jobs growth far exceeded expectations. The tech-heavy advanced 1.8 percent to 7,560.81 and hit intraday and closing records, erasing the losses from last month's ...
more»
01:33 | 12/3/18
MoneyMakingArticles
Among 7 analysts covering Atara Biotherapeutics (NASDAQ:ATRA), 4 have Buy rating, 1 Sell and 2 Hold. Therefore 57% are positive. Atara Biotherapeutics had 23 analyst reports since September 9, 2015 according to SRatingsIntel.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |